P&S Robotics Co., Ltd. (KOSDAQ:460940)
South Korea · Delayed Price · Currency is KRW 20,900
+600 (2.96%)
Oct 31, 2025, 1:40 PM KST
P&S Robotics Revenue
P&S Robotics had revenue of 2.65B KRW in the quarter ending June 30, 2025, with 57.30% growth. This brings the company's revenue in the last twelve months to 9.19B, up 50.25% year-over-year. In the year 2024, P&S Robotics had annual revenue of 7.11B with 18.24% growth.
Revenue (ttm)
9.19B
Revenue Growth
+50.25%
P/S Ratio
14.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
131.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.11B | 1.10B | 18.24% |
| Dec 31, 2023 | 6.01B | 794.72M | 15.24% |
| Dec 31, 2022 | 5.21B | -600.26M | -10.32% |
| Dec 31, 2021 | 5.81B | 2.78B | 91.37% |
| Dec 31, 2020 | 3.04B | -780.05M | -20.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |